心室辅助装置（VAD）治疗20/20：超越对一种新兴治疗方法的短视观点。
VAD therapy 20/20: moving beyond the myopic view of a nascent therapy.
作者信息
DeVore Adam D, Milano Carmelo A, Rogers Joseph G
机构信息
1 Duke Clinical Research Institute, 2 Department of Medicine, 3 Division of Cardiothoracic Surgery, Duke University School of Medicine, Durham, NC 27715, USA.
出版信息
Ann Cardiothorac Surg. 2014 Nov;3(6):603-5. doi: 10.3978/j.issn.2225-319X.2014.08.22.
Abstract
The past five years have seen remarkable growth in the use of durable, continuous flow left ventricular assist devices (LVAD) with associated improvements in mortality, quality of life, functionality and end-organ function. To sustain the growth of this important therapy, the LVAD community must now address key issues focused around the costs of LVAD care, refined patient selection, and reducing complications associated with this therapy. In this perspective piece, we discuss many of these issues.
摘要
在过去五年中，耐用的连续血流左心室辅助装置（LVAD）的使用显著增加，患者的死亡率、生活质量、功能和终末器官功能也随之改善。为了维持这一重要治疗方法的发展，LVAD领域现在必须解决一些关键问题，这些问题主要围绕LVAD治疗的成本、优化患者选择以及减少与该治疗相关的并发症。在这篇观点文章中，我们将讨论其中的许多问题。
相似文献
1
VAD therapy 20/20: moving beyond the myopic view of a nascent therapy.心室辅助装置（VAD）治疗20/20：超越对一种新兴治疗方法的短视观点。
Ann Cardiothorac Surg. 2014 Nov;3(6):603-5. doi: 10.3978/j.issn.2225-319X.2014.08.22.
2
Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.体外生命支持过渡到心室辅助装置：双桥策略。
Artif Organs. 2016 Jan;40(1):100-6. doi: 10.1111/aor.12496. Epub 2015 May 15.
3
Left ventricular assist devices and their complications: A review for emergency clinicians.左心室辅助装置及其并发症：急诊临床医生的综述。
Am J Emerg Med. 2019 Aug;37(8):1562-1570. doi: 10.1016/j.ajem.2019.04.050. Epub 2019 May 6.
4
Understanding Left Ventricular Assist Devices.了解左心室辅助设备。
Blood Purif. 2018;46(4):292-300. doi: 10.1159/000491872. Epub 2018 Jul 26.
5
Comparison of paracorporeal and continuous flow ventricular assist devices in children: preliminary results.儿童体外和连续流心室辅助装置的比较：初步结果。
Eur J Cardiothorac Surg. 2017 Apr 1;51(4):709-714. doi: 10.1093/ejcts/ezx006.
6
Continuous flow left ventricular assist devices: a valid option for heart failure patients.持续血流左心室辅助装置：心力衰竭患者的有效选择。
Swiss Med Wkly. 2012 Oct 18;142:w13701. doi: 10.4414/smw.2012.13701. eCollection 2012.
7
To ventricular assist devices or not: When is implantation of a ventricular assist device appropriate in advanced ambulatory heart failure?是否使用心室辅助装置：晚期门诊心力衰竭患者何时适合植入心室辅助装置？
World J Cardiol. 2016 Dec 26;8(12):695-702. doi: 10.4330/wjc.v8.i12.695.
8
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.心力衰竭晚期连续血流左心室辅助装置的临床管理。
J Heart Lung Transplant. 2010 Apr;29(4 Suppl):S1-39. doi: 10.1016/j.healun.2010.01.011. Epub 2010 Feb 24.
9
Durability of continuous-flow left ventricular assist devices: a systematic review.连续流左心室辅助装置的耐久性：一项系统评价
Ann Cardiothorac Surg. 2014 Nov;3(6):547-56. doi: 10.3978/j.issn.2225-319X.2014.11.01.
10
[Therapeutic options in advanced heart failure : place of durable left ventricular assist device (LVAD)].晚期心力衰竭的治疗选择：持久性左心室辅助装置（LVAD）的地位
Rev Med Suisse. 2018 May 23;14(608):1070-1077.
引用本文的文献
1
Longitudinal Heart Failure Medication Use and Adherence Following Left Ventricular Assist Device Implantation in Privately Insured Patients.私营保险患者左心室辅助装置植入后的心力衰竭药物使用和依从性的纵向研究。
J Am Heart Assoc. 2017 Oct 3;6(10):e005776. doi: 10.1161/JAHA.117.005776.
本文引用的文献
1
Sixth INTERMACS annual report: a 10,000-patient database.国际机械循环辅助装置注册研究（INTERMACS）第六年度报告：一个包含10000名患者的数据库。
J Heart Lung Transplant. 2014 Jun;33(6):555-64. doi: 10.1016/j.healun.2014.04.010. Epub 2014 Apr 21.
2
Anticoagulation in atrial fibrillation.心房颤动的抗凝治疗。
BMJ. 2014 Apr 14;348:g2116. doi: 10.1136/bmj.g2116.
3
Moving beyond "bridges".超越“桥梁”。
JACC Heart Fail. 2013 Oct;1(5):379-81. doi: 10.1016/j.jchf.2013.08.003. Epub 2013 Oct 7.
4
Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).植入策略随时间而变化，并影响结果：来自 INTERMACS（机械循环辅助支持机构间注册中心）的见解。
JACC Heart Fail. 2013 Oct;1(5):369-78. doi: 10.1016/j.jchf.2013.05.006. Epub 2013 Sep 11.
5
The vexing problem of thrombosis in long-term mechanical circulatory support.长期机械循环辅助中令人困扰的血栓问题。
J Heart Lung Transplant. 2014 Jan;33(1):1-11. doi: 10.1016/j.healun.2013.12.002. Epub 2013 Dec 10.
6
Unexpected abrupt increase in left ventricular assist device thrombosis.左心室辅助装置血栓形成的意外急剧增加。
N Engl J Med. 2014 Jan 2;370(1):33-40. doi: 10.1056/NEJMoa1313385. Epub 2013 Nov 27.
7
Dabigatran versus warfarin in patients with mechanical heart valves.达比加群酯与华法林用于机械心脏瓣膜患者的比较。
N Engl J Med. 2013 Sep 26;369(13):1206-14. doi: 10.1056/NEJMoa1300615. Epub 2013 Aug 31.
8
Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.第五次 INTERMACS 年度报告：来自 6000 多名机械循环支持患者的风险因素分析。
J Heart Lung Transplant. 2013 Feb;32(2):141-56. doi: 10.1016/j.healun.2012.12.004.
9
Cerebrovascular complications of left ventricular assist devices.左心室辅助装置的脑血管并发症。
Eur J Cardiothorac Surg. 2012 Oct;42(4):612-20. doi: 10.1093/ejcts/ezs320. Epub 2012 Jun 1.
10
Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.连续血流左心室辅助装置作为终末期心力衰竭治疗的成本效果分析。
Circ Heart Fail. 2012 Jan;5(1):10-6. doi: 10.1161/CIRCHEARTFAILURE.111.962951. Epub 2011 Nov 3.
Zotero 插件